PREDICTIMMUNE
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.
PREDICTIMMUNE
Industry:
Biopharma Biotechnology Health Care Life Science Medical Medical Device
Founded:
2017-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.predictimmune.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)1223 804 195
Email Addresses:
[email protected]
Total Funding:
31.44 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network LetsEncrypt
Similar Organizations
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
TPM
Tpm.bio specializes in research, life sciences services, training on medical devices, and innovation in the biomedical field.
Current Advisors List
Current Employees Featured
Founder
Investors List
Crohn's & Colitis Foundation
Crohn's & Colitis Foundation investment in Grant - PredictImmune
Parkwalk Advisors
Parkwalk Advisors investment in Series A - PredictImmune
Parkwalk Advisors
Parkwalk Advisors investment in Series B - PredictImmune
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - PredictImmune
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series B - PredictImmune
Business Growth Fund
Business Growth Fund investment in Series B - PredictImmune
Innovate UK
Innovate UK investment in Grant - PredictImmune
Wellcome Trust
Wellcome Trust investment in Grant - PredictImmune
Parkwalk Advisors
Parkwalk Advisors investment in Series A - PredictImmune
Wren Capital
Wren Capital investment in Series A - PredictImmune
Official Site Inspections
http://www.predictimmune.com Semrush global rank: 10.15 M Semrush visits lastest month: 253
- Host name: 192.64.119.79
- IP address: 192.64.119.79
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "PredictImmune"
PredictImmune - Crunchbase Company Profile & Funding
PredictImmune may be growing as evidenced by the company winning a £100K grant for the study of IBD prognostic, which indicates an injection of funds to support its research and …See details»
Predictimmune and the Crohn’s & Colitis Foundation Announce a …
Dec 4, 2018 CAMBRIDGE, England—PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, …See details»
PredictImmune Company Profile 2024: Valuation, Funding
PredictImmune General Information Description. Developer of prognostic tools designed to guide treatment options in immune-mediated inflammatory diseases. The company's products offer …See details»
PredictImmune - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Series A - PredictImmune — …See details»
Cambridge spin-out PredictImmune closes Series B, raising £10m
Jul 30, 2019 Cambridge Enterprise portfolio company PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune …See details»
PredictImmune - Contacts, Employees, Board Members, Advisors …
Organization. PredictImmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Number of …See details»
PredictImmune, KSL announce new strategic partnership for …
Nov 17, 2019 PredictImmune’s CEO, Paul Kinnon commented: “PredictSURE IBDâ„¢ is a major step towards personalised medicine in IBD and we are delighted that via our partnership with …See details»
Spin-out PredictImmune wins £4.3m from Wellcome to evaluate its ...
PredictImmune, a developer of prognostic tools to guide treatment of patients with immune-mediated diseases, announced today that it has been awarded £4.3m by the Wellcome Trust.. …See details»
Cambridge Enterprise invests in PredictImmune
May 18, 2017 Predictimmune will develop similar predictive tests for other significant diseases, which fall into the same immune-mediated category, including lupus, multiple sclerosis, …See details»
www.predictimmune.com
Www.predictimmune.comSee details»
PredictImmune Raises €11M to Market Personalized Medicine Test
Jul 31, 2019 The UK biotech PredictImmune has raised €11M (£10M) in a Series B fundraising round to commercialize technology to predict the progress of inflammatory bowel disease in …See details»
PredictImmune: Predicting outcomes in Inflammatory Bowel …
PredictImmune is the manufacturer and distributer of PredictSURE IBD, a CE marked assay (since 2018) which has been available for commercial use through the East Genomic …See details»
PredictImmune: a blood test to tailor treatment for bowel condition
Jun 30, 2020 PredictImmune is a spin-off from the University of Cambridge, UK. Diagnosing inflammatory bowel disease (IBD) is relatively straightforward. Through a combination of tests …See details»
PredictImmune secures $5.9M in funding for its Crohn’s disease ...
Apr 30, 2018 PredictImmune, a U.K.-based developer of diagnostics, secured $5.9 million (£4.3 million) in funding from the Wellcome Trust that will be used for a multisite clinical trial of its …See details»
New agreement with Cambridge spin-out PredictImmune lets SLE …
Sep 19, 2019 PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed the …See details»
PredictImmune - IBD Relief
About PredictSURE IBDâ„¢ Award-winning PredictSURE IBDâ„¢, made by PredictImmune, is the world’s first validated and CE-marked prognostic test for guiding treatment options in …See details»
Guiding IBD treatment with PredictImmune - Tier 2
PredictImmune aims to develop and commercialise a series of biomarker tests to guide physicians in the treatment of patients with immune-mediated disease, through prediction of long-term …See details»
PredictImmune’s first prognostic test for IBD, PredictSURE IBD ...
Cambridge, UK, 2nd April: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today …See details»
PredictImmune Partners with Foundation on Study to Validate IBD …
Nov 7, 2019 PredictImmune successfully launched the test in the U.K. and Ireland in April, and since then has worked to expand the test’s distribution worldwide. On October 22, …See details»
PredictImmune: a blood test to tailor treatment for bowel
PredictImmune: a blood test to tailor treatment for bowel condition Nature. 2020 Jun 30. doi: 10.1038/d41586-020-01804-9. Online ahead of print. Author Elie Dolgin. PMID: 32606407 …See details»